Living donor liver transplantation for hepatitis B cirrhosis.
Articles > Article · 2007
Authors: Abdullah Zeki KARASU, Murat AKYILDIZ, Murat KILIÇ, Murat ZEYTÜNLÜ, Unal AYDIN, Fatih TEKİN, Funda YILMAZ BARBET, Tijen OZACAR, Ulus Salih AKARCA, Galip ERSÖZ, Fulya GÜNŞAR, Tankut ILTER, Michael R. LUCEY
Journal of gastroenterology and hepatology, Journal Indexed in SCI Expanded, International, 2007, vol 22, pp 2124-2129
DOI: 10.1111/j.1440-1746.2006.04782.x
Summary
Background and Aim: Living donor liver transplantation (LDLT) has particular advantages for Turkey where hepatitis B virus (HBV) infection is the most common cause of cirrhosis, both because LDLT circumvents the difficulties encountered in the emerging world in providing deceased donor organs, and because it allows preemptive antiviral therapy. The aim of this study was to review one institution's experience with LDLT in patients with chronic HBV infection.